- ►annals.org [PDF] AD Mooradian, M Bernbaum, SG Albert - Annals of internal medicine, 2006 - Am Coll Physicians Background: The emergence of multiple insulin products has pro- vided new
opportunities to achieve diabetes control. However, the number of options has
raised concerns about the optimal choices of products. Cited by 46 - Related articles - BL Direct - All 8 versions
- ►adisonline.com [PDF] R Oiknine, M Bernbaum, AD Mooradian - Drugs, 2005 - pt.wkhealth.com Insulin is one of the oldest and best studied treatments for diabetes mellitus.
Despite many improvements in the management of diabetes, the nonphysiological
time-action profiles of conventional insulins remain a significant ... Cited by 59 - Related articles - All 5 versions
HE Lebovitz - Endocrine Practice, 2006 - AACE Basic research during the past 2 decades has provided the foundation for the
development of numerous new pharmacologic agents and technologies for the
treatment of type 2 diabetes, insulin resistance, and the components of the ... Cited by 16 - Related articles - BL Direct - All 2 versions
[CITATION] Therapeutic effectiveness of two insulin regimens for insulin naive patients with type 2 …
S Luzio, G Dunseath, R Peter, V Pauvaday, … - Diabetologia, 2006 - Springer Abstract Aims/hypothesis: The pharmacokinetic and pharmacodynamic properties of
biphasic insulin aspart (BIAsp 30) (30% soluble, 70% protaminated insulin aspart
[IAsp]) and insulin glargine (IGlarg) were compared. Methods: Twelve people ... Cited by 31 - Related articles - BL Direct - All 3 versions
H Gin, H Hanaire-Broutin - Diabetes and Metabolism, 2005 - Elsevier Insulin-treated patients are generally taught to adapt their doses of insulin
according to the glycemic level obtained during self-tests. They usually adhere
to medical recommendations, but are often confused by the results, which ... Cited by 30 - Related articles - All 3 versions
R Oiknine, AD Mooradian - Biomedicine & Pharmacotherapy, 2003 - Elsevier The prevalence of type 2 diabetes mellitus is increasing in the elderly.
Although type 1 diabetic patients are living longer, over 95% of elderly people
affected with diabetes have type 2 diabetes. This segment of the ... Cited by 18 - Related articles - All 5 versions
B Guerci, JP Sauvanet - Diabetes and Metabolism, 2005 - Elsevier The therapeutic goal in insulin-treated diabetic patients is to maintain on the
long-term a tight glucose control (HbA1 c < 6,5-7% or less) through an insulin
regimen which “mimic” the physiological insulin profile: a basal ... Cited by 34 - Related articles - BL Direct - All 3 versions
